title: [Current approaches to smoking cessation].
abstract: Smoking causes about 5 Million deaths worldwide every year. Prevention and cessation of smoking should therefore be one of the most important public health priorities. The family doctor as a trusted contact and representative of the health care system plays an important role in this case. Smoking cessation can be achieved by a gradual cognitive-behavioral therapy which may be supported by pharmacotherapy. The continuous empathic support and motivation by the family doctor is however the most important factor. Even a small advance within this step-by-step strategy can be considered as a success which will be followed by further progress.
authors.affiliation: Institut für Raucherberatung & Tabakentwöhnung, München.
authors.forename: P L
authors.initials: PL
authors.lastname: Bölcskei
authors.forename: P
authors.initials: P
authors.lastname: Davis-Wagner
authors.forename: J
authors.initials: J
authors.lastname: Grundnig
authors.forename: P
authors.initials: P
authors.lastname: Pommer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D003299:Cooperative Behavior; D003430:Cross-Sectional Studies; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D005260:Female; D005858:Germany; D006292:Health Priorities; D006306:Health Surveys; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000627:therapeutic use; D010817:Physician-Patient Relations; D011810:Quinoxalines / Q000627:therapeutic use; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology / Q000401:mortality; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D012944:Social Support; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000453:epidemiology / Q000523:psychology / Q000534:rehabilitation*; D000068580:Varenicline; D055815:Young Adult
chemical_list: D001552:Benzazepines; D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D000068580:Varenicline